Guide to FDA 510(k) Labeling and Instructions for Use (IFU)

Your device labeling is not just marketing material; it's a critical component of your 510(k) submission that is legally binding and heavily scrutinized by the FDA. Inconsistent or incomplete labeling is a common reason for an Additional Information request. All labeling must comply with FDA regulations, primarily 21 CFR 801.

What Does "Labeling" Include?

The term "labeling" is broad and covers all written, printed, or graphic matter accompanying your device. For a 510(k), you must submit a complete, final draft of all labeling, including:

Ensure Perfect Consistency Across Your Submission.

Is the Indications for Use statement in your IFU identical to the one in your submission's cover letter? Cruxi's AI ensures consistency across all documents, cross-referencing your labeling with your device description and SE narrative to eliminate costly errors.

Draft Consistent Documentation with AI

Key Requirements for the Instructions for Use (IFU)

The IFU is a comprehensive technical document. It must be clear, concise, and written for the intended user (e.g., a surgeon, a lab technician, a patient).

The Unique Device Identification (UDI) System

Your device label must comply with the FDA's UDI system. The UDI is a unique numeric or alphanumeric code that consists of two parts:

The UDI must be presented in both a plain-text version and a machine-readable format (e.g., a barcode or QR code). Your 510(k) submission must include a draft label showing the UDI in its final format.